Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

Episode 25 November 17, 2022 00:39:44
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

Nov 17 2022 | 00:39:44

/

Show Notes

“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to discuss the necessity and viability of orphan and rare disease research - for both patients and VC investors alike.

 

Other Episodes

Episode 40

April 25, 2024 00:33:23
Episode Cover

Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

"I learned very early on that the stupidest cancer cell was cleverer than the cleverest oncologist." - Justin Stebbing, Editor-in-Chief of Oncogene, previously the...

Listen

Episode 50

March 18, 2025 00:52:02
Episode Cover

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia?...

Listen

Episode 18

March 23, 2022 00:55:46
Episode Cover

Episode 18: Karen Petrou and David Brint - BioBonds

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on...

Listen